TerminatedPhase 3NCT00268372
S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx
Studying Squamous cell carcinoma of the oropharynx
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- SWOG Cancer Research Network
- Principal Investigator
- David J. Adelstein, MDThe Cleveland Clinic
- Intervention
- cisplatin(drug)
- Enrollment
- 6 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2005 – 2007
Study locations (30)
- Eastern Connecticut Hematology and Oncology Associates, Norwich, Connecticut, United States
- Rush-Copley Cancer Care Center, Aurora, Illinois, United States
- John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, United States
- Veterans Affairs Medical Center - Hines, Hines, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West, Joliet, Illinois, United States
- Trinity Medical Center - East, Moline, Illinois, United States
- Moline, Illinois, United States
- West Suburban Center for Cancer Care, River Forest, Illinois, United States
- Regional Cancer Center at Memorial Medical Center, Springfield, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital, Urbana, Illinois, United States
- CCOP - Carle Cancer Center, Urbana, Illinois, United States
- Saint Anthony Memorial Health Centers, Michigan City, Indiana, United States
- Bettendorf, Iowa, United States
- Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00268372 on ClinicalTrials.govOther trials for Squamous cell carcinoma of the oropharynx
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06915038ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the OropharynxIndiana University
- RECRUITINGPHASE1NCT06747390Intratumoral Lidocaine Injection Before Oropharyngeal Cancer SurgeryRyan Carey
- RECRUITINGPHASE2NCT06702033The Minimalist Trial-2Washington University School of Medicine
- RECRUITINGPHASE1NCT06589609Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal CancerBlueSky Immunotherapies GmbH
- RECRUITINGPHASE2NCT06223568Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) CancerNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT05582122SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal CancersUNICANCER
- ACTIVE NOT RECRUITINGNCT06592716Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?Rigshospitalet, Denmark
- RECRUITINGPHASE2NCT06323460Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal CancerOhio State University Comprehensive Cancer Center
See all trials for Squamous cell carcinoma of the oropharynx →